T H 1/T H 17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus-Reference-Cited by-同舟云学术

T H 1/T H 17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus

Published:2018-08 Issue:2 Volume:142 Page:669-672.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Schmidt Thomas,Solimani Farzan,Pollmann Robert,Stein Ronja,Schmidt Ansgar,Stulberg Inna,Kühn Katja,Eming Rüdiger,Eubel Verena,Kind Peter,Arweiler Nicole,Sitaru Cassian,Hertl Michael

Funder

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus;Baldo;J Eur Acad Dermatol Venereol,2010

2. T cell control in autoimmune bullous skin disorders;Hertl;J Clin Invest,2006

3. Dichotomy of autoreactive Th1 and Th2 cell responses to Dsg3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles;Veldman;J Immunol,2003

4. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls;Büdinger;J Clin Invest,1998

5. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus;Piccinni;Oral Dis,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08-16

2. Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study;British Journal of Dermatology;2024-05-13

3. Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review;Frontiers in Immunology;2024-04-15

4. TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planus;Experimental Dermatology;2024-04

5. Lichen Planus and Lichenoid Disorders;Rook's Textbook of Dermatology;2024-03-19